Jupiter Neurosciences, Inc. (JUNS): Cost of Revenue
$4.2K
Year ended 2025-12-31
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.2K | n/a | 2026-04-01, From 2025-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $4.2K | n/a |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $5.8K | -33.1% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $70.0K | n/a |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $424.0K | n/a |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $43.4K | -97.3% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $44.3K | +658.7% |
| Aspire Biopharma Holdings, Inc. (ASBP) | 2025-12-31 | $6.3K | n/a |
| One World Products, Inc. (OWPC) | 2024-12-31 | $948 | -99.5% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $94.8K | n/a |
Compare JUNS, BDPT, PRFX, IBO side by side · Screen every company in Pharmaceutical Preparations ↗